FdaApplication
NDA 217225
Identifiers
- fda_app_no: NDA217225
Properties
| Property | Value |
|---|---|
| applicant_name | ASTELLAS PHARMA US INC |
| application_type | NDA |
| approval_date | 2023-08-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IZERVAY | AVACINCAPTAD PEGOL SODIUM | EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) | SOLUTION;INTRAVITREAL |
1 product